NEURAL CELL-ADHESION MOLECULE (CD56) EXPRESSION IS ASSOCIATED WITH FAB SUBTYPE, CYTOGENETICS AND SKIN INFILTRATION IN ACUTE MYELOID-LEUKEMIA (AML)

被引:0
|
作者
SEYMOUR, JF [1 ]
PIERCE, SA [1 ]
KANTARJIAN, H [1 ]
KEATING, MJ [1 ]
ESTEY, EH [1 ]
机构
[1] MD ANDERSON CANC CTR,HOUSTON,TX
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A126 / A126
页数:1
相关论文
共 48 条
  • [41] ACUTE MYELOID-LEUKEMIA BLAST CELLS BIND TO HUMAN ENDOTHELIUM IN-VITRO UTILIZING E-SELECTIN AND VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1)
    CAVENAGH, JD
    GORDONSMITH, EC
    GIBSON, FM
    GORDON, MY
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (02) : 285 - 291
  • [42] Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation
    Yang, Deok-Hwan
    Lee, Je-Jung
    Mun, Yeung-Chul
    Shin, Ho-Jin
    Kim, Yeo-Kyeoung
    Cho, Sang-Hee
    Chung, Ik-Joo
    Seong, Chu-Myong
    Kim, Hyeoung-Joon
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (01) : 1 - 5
  • [43] Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation
    Ely, SA
    Knowles, DM
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (04): : 1293 - 1299
  • [44] STEM CELL TRANSPLANT (SCT) OVERCOMES THE POOR PROGNOSIS ASSOCIATED WITH CD25 EXPRESSION IN ACUTE MYELOID LEUKEMIA (AML): ARETROSPECTIVE SINGLE CENTER ANALYSIS
    Cerny, J.
    Ramanathan, M.
    Yu, H.
    Raffel, G. D.
    Walsh, W., V
    Petrillo-Deluca, L. J.
    Tarrasky, N.
    O'Rourke, E.
    Bednarik, J.
    Hao, S.
    Hutchinson, L.
    Woda, B.
    Barton, B.
    Rosmarin, A. G.
    Nath, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S292 - S293
  • [45] CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy
    Fischer, Lars
    Goekbuget, Nicola
    Schwartz, Stefan
    Burmeister, Thomas
    Rieder, Harald
    Brueggemann, Monika
    Hoelzer, Dieter
    Thiel, Eckhard
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 224 - 229
  • [46] Expression of CD25 on Acute Myeloid Leukemia (AML) Blasts Is An Independent Risk Factor Associated with Refractory Disease, Which May Be Overcome by Stem Cell Transplantation (SCT)
    Cerny, Jan
    Woods, Lesley
    Yu, Hongbo
    Ramanathan, Muthalagu
    Raffel, Glen D.
    Walsh, William V.
    Petrillo-Deluca, Laura J.
    Tarrasky, Natasha M.
    O'Rourke, Elizabeth
    Bednarik, Jayde L.
    Woda, Bruce
    Hutchinson, Lloyd
    Kroll, Aimee
    Barton, Bruce
    Rosmarin, Alan G.
    Nath, Rajneesh
    BLOOD, 2011, 118 (21) : 1519 - 1519
  • [47] LOCALIZATION OF AML1/ETO-TRANSCRIPTS IN A CD56+ LEUKOCYTE SUBSET AND IN THE CFU-GM PERIPHERAL STEM-CELL FRACTION IN PATIENTS WITH T(8-21)-POSITIVE ACUTE MYELOID-LEUKEMIA IN REMISSION
    MITTERBAUER, M
    KUSEC, R
    STROBL, H
    SCHEINECKER, C
    OEHLER, L
    SCHWARZINGER, I
    GEISSLER, K
    HAAS, OA
    KNAPP, W
    LECHNER, K
    BLOOD, 1994, 84 (10) : A610 - A610
  • [48] A case report on a patient who presented with myelofibrosis, developed breast cancer with myeloid metaplasia, and finally showed immature NK-cell leukemia or AML without maturation with CD56 expression transformation in the pleura with extramedullary hematopoiesis: A 25-year course
    Oka, Kuniyuki
    Nagayama, Reizo
    Yonekawa, Nobuo
    Koyamatsu, Sumiko
    Mori, Naoyoshi
    PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (05) : 319 - 322